Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • simon.jarman@aad.gov.au
    Junior Member
    • May 2009
    • 5

    #1

    Velvet/Oases transcript expression level?

    Hi,
    I am in the process of de novo transcriptome assembly from a non-model eukaryote. I have 17 million 65 bp, paired-end reads that I have assembled with Velvet and then Oases. This gives nice results in that I am getting full-length contigs that appear reasonable when compared to orthologues in related model eukaryotes. However, I am really after relative transcript expression levels. Does anyone know if there as a way that I can get information on that from this software combination?
  • konrad98
    Member
    • Jan 2009
    • 17

    #2
    Hi Simon,

    I'm not by any means an expert on this, but you probably have two options:

    1. Convert the kmer coverage in the stats.txt file to base-coverage and use that as a proxy for expression level

    2. Align the reads to the assembled transcripts using something like Bowtie and then extract the coverage of each transcript using SAMTools

    Hope that helps!

    Comment

    • choy
      Member
      • Jul 2009
      • 14

      #3
      Velvet question

      How can one extract all of the reads that were used in the assembly, in order to do the re-mapping step you described?

      Comment

      • konrad98
        Member
        • Jan 2009
        • 17

        #4
        Under the contrib/extractContigReads directory in Velvet you'll find a script to do this

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...